CRISPR from Research to Therapy
The recent approval of the first non-viral CRISPR-based gene therapy once again underlines the therapeutic and life-changing potential of this groundbreaking genome editing technology.
Benefit from the knowledge and protocols published by your peers for implementing CRISPR or other genome editing techniques into your research and manufacturing. Learn from our selection of scientific publications how researchers have been using the Nucleofector® Electroporation Technology for genome editing applications for more than a decade.
With more than 10,000 publications just for CRISPR-based applications comprising newer variations like base or prime editing, the Nucleofector® Technology has become an established benchmark transfection technology for genome editing tools.
Download our Genome Editing Publication List:
- Comprising 180+ selected publications
- Covering tools from CRISPR/Cas9, to TALEN®, ZFN and Sleeping Beauty® or PiggyBac® transposon/transposase
- Including latest advancements like prime and base editing
- Comprehensibly sorted by technology
